Sustained Delivery of Chondroitinase ABC from Hydrogel System
Source abstract
Abstract
In the injured spinal cord, chondroitin sulfate proteoglycans (CSPGs) are the principal responsible of axon growth inhibition and they contribute to regenerative failure, promoting glial scar formation. Chondroitinase ABC (chABC) is known for being able to digest proteoglycans, thus degrading glial scar and favoring axonal regrowth. However, its classic administration is invasive, infection-prone and clinically problematic. An agarose-carbomer (AC1) hydrogel, already used in SCI repair strategies, was here investigated as a delivery system capable of an effective chABC administration: the material ability to include chABC within its pores and the possibility to be injected into the target tissue were firstly proved. Subsequently, release kinetic and the maintenance of enzymatic activity were positively assessed: AC1 hydrogel was thus confirmed to be a feasible tool for chABC delivery and a promising device for spinal cord injury topic repair strategies.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nerve injury and regeneration · Proteoglycans and glycosaminoglycans research · Hydrogels: synthesis, properties, applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemistry, Materials and Chemical Engineering “Giulio Natta”, Politecnico di Milano, via Mancinelli 7, Milan 20131, Italy
Department of Neuroscience, Mario Negri Institute for Pharmacological Research, via La Masa 19, Milan 20156, Italy
References (29)
Show source-provided references
1. Incidence of spinal cord injury worldwide: A systematic review10.1159/000279335 ↗
2. Outcome measures: Evolution in clinical trials of neurological/functional recovery in spinal cord injury10.1038/sc.2009.198 ↗
3. Trajectories in the course of life satisfaction after spinal cord injury: Identification and predictors10.1016/j.apmr.2010.10.011 ↗
4. Nanotechnology for treatment of stroke and spinal cord injury10.2217/nnm.09.93 ↗
5. Manipulating the glial scar: Chondroitinase ABC as a therapy for spinal cord injury10.1016/j.brainresbull.2010.06.015 ↗
6. Opinion—Spinal cord repair strategies: Why do they work?10.1038/nrn1964 ↗
7. Sustained delivery of thermostabilized chABC enhances axonal sprouting and functional recovery after spinal cord injury10.1073/pnas.0905437106 ↗
8. Chondroitinase treatment following spinal contusion injury increases migration of oligodendrocyte progenitor cells10.1016/j.expneurol.2011.05.002 ↗
9. Controlled release of chondroitinase ABC from fibrin gel reduces the level of inhibitory glycosaminoglycan chains in lesioned spinal cord10.1016/j.jconrel.2010.06.026 ↗
10. Perspectives and challenges in tissue engineering and regenerative medicine10.1002/adma.200902589 ↗
11. Intrathecal delivery of a polymeric nanocomposite hydrogel after spinal cord injury10.1016/j.biomaterials.2010.07.004 ↗
12. Hydrogels in regenerative medicine10.1002/adma.200802106 ↗
13. Hydrogels in spinal cord injury repair strategies10.1021/cn200030w ↗
14. In situ agar-carbomer polycondensation: A chemical approach to regenerative medicine10.1016/j.matlet.2011.02.036 ↗
15. Characterization and degradation behavior of agar—Carbomer based hydrogels for drug delivery applications: Solute effect10.3390/ijms12063394 ↗
16. Smart approach to evaluate drug diffusivity in injectable agar-carbomer hydrogels for drug delivery10.1021/jp1111394 ↗
17. Perale, G., Rossi, F., Santoro, M., Peviani, M., Papa, S., Llupi, D., Torriani, P., Micotti, E., Previdi, S., Cervo, L., Sundstrom, E., Boccaccini, A.R., Masi, M., Forloni, G., and Veglianese, P. (2012). Multiple drug delivery hydrogel system for spinal cord injury repair strategies. J. Control Release, in press.10.1016/j.jconrel.2011.12.025 ↗
18. In vivo diffusion analysis with quantum dots and dextrans predicts the width of brain extracellular space10.1073/pnas.0509425103 ↗
19. Crystal structure of proteus vulgaris chondroitin sulfate ABC lyase I at 1.9 A resolution10.1016/S0022-2836(03)00345-0 ↗
20. Biological buffered saline solution as solvent in agar-carbomer hydrogel synthesis10.2478/s11696-010-0052-4 ↗
21. Injectable hydrogels as unique biomedical materials10.1039/b713009k ↗
22. Synthesis of macroporous thermosensitive hydrogels: A novel method of controlling pore size10.1021/la8038939 ↗
23. Thermosensitive injectable hyaluronic acid hydrogel for adipose tissue engineering10.1016/j.biomaterials.2009.08.058 ↗
24. Agarose gel stiffness determines rate of DRG neurite extension in 3D cultures10.1016/S0142-9612(00)00350-1 ↗
25. Rheological, mechanical and mucoadhesive properties of thermoresponsive, bioadhesive binary mixtures composed of poloxamer 407 and carbopol 974P designed as platforms for implantable drug delivery systems for use in the oral cavity10.1016/j.ijpharm.2009.01.006 ↗
26. A thixotropic hydrogel from chemically cross-linked guar gum: Synthesis, characterization and rheological behaviour10.1016/j.carres.2008.08.029 ↗
27. Controlled release of functional proteins through designer self-assembling peptide nanofiber hydrogel scaffold10.1073/pnas.0807506106 ↗
28. Degradation of decorin by matrix metalloproteinases: Identification of the cleavage sites, kinetic analyses and transforming growth factor-beta1 release10.1042/bj3220809 ↗
29. Purification and characterization of decorin from the culture media of MRC-5 cells10.1016/j.biocel.2004.01.023 ↗